| Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea E Belaidi, M Joyeux-Faure, C Ribuot, SH Launois, P Levy, ... Journal of the American College of Cardiology 53 (15), 1309-1317, 2009 | 224 | 2009 |
| Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials I Jullian-Desayes, M Joyeux-Faure, R Tamisier, S Launois, AL Borel, ... Sleep medicine reviews 21, 23-38, 2015 | 213 | 2015 |
| Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia A Ramond, D Godin‐Ribuot, C Ribuot, P Totoson, I Koritchneva, S Cachot, ... Fundamental & clinical pharmacology 27 (3), 252-261, 2013 | 193 | 2013 |
| Acute intermittent hypoxia improves rat myocardium tolerance to ischemia PC Beguin, M Joyeux-Faure, D Godin-Ribuot, P Levy, C Ribuot Journal of applied physiology 99 (3), 1064-1069, 2005 | 162 | 2005 |
| Chronic intermittent hypoxia increases infarction in the isolated rat heart M Joyeux-Faure, F Stanke-Labesque, B Lefebvre, P Beguin, ... Journal of applied physiology 98 (5), 1691-1696, 2005 | 130 | 2005 |
| Cellular protection by erythropoietin: new therapeutic implications? M Joyeux-Faure Journal of Pharmacology and Experimental Therapeutics 323 (3), 759-762, 2007 | 112 | 2007 |
| Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease D Viglino, I Jullian-Desayes, M Minoves, J Aron-Wisnewsky, V Leroy, ... European Respiratory Journal 49 (6), 2017 | 98 | 2017 |
| Erythropoietin and myocardial protection: what's new? M Joyeux‐Faure, D Godin‐Ribuot, C Ribuot Fundamental & clinical pharmacology 19 (4), 439-446, 2005 | 72 | 2005 |
| Multimodal remote monitoring of high cardiovascular risk patients with OSA initiating CPAP: a randomized trial JL Pépin, I Jullian-Desayes, M Sapène, E Treptow, M Joyeux-Faure, ... Chest 155 (4), 730-739, 2019 | 68 | 2019 |
| Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat B Lefebvre, D Godin-Ribuot, M Joyeux-Faure, F Caron, G Bessard, P Lévy, ... Respiratory physiology & neurobiology 150 (2-3), 278-286, 2006 | 65 | 2006 |
| Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia P Totoson, W Fhayli, G Faury, I Korichneva, S Cachot, M Baldazza, ... Experimental Biology and Medicine 238 (2), 223-232, 2013 | 62 | 2013 |
| Diagnosis and management of central sleep apnea syndrome S Baillieul, B Revol, I Jullian-Desayes, M Joyeux-Faure, R Tamisier, ... Expert review of respiratory medicine 13 (6), 545-557, 2019 | 59 | 2019 |
| Fructose-fed rat hearts are protected against ischemia-reperfusion injury MJ Faure, E Rossini, C Ribuot, P Faure Experimental Biology and Medicine 231 (4), 456-462, 2006 | 56 | 2006 |
| Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP‐dependent potassium channels in the rat heart M Joyeux‐Faure, A Ramond, PC Beguin, E Belaidi, D Godin‐Ribuot, ... Fundamental & clinical pharmacology 20 (1), 51-56, 2006 | 55 | 2006 |
| Heat stress preconditioning and delayed myocardial protection: what is new? M Joyeux-Faure, C Arnaud, D Godin-Ribuot, C Ribuot Cardiovascular research 60 (3), 469-477, 2003 | 55 | 2003 |
| Continuous positive airway pressure reduces night-time blood pressure and heart rate in patients with obstructive sleep apnea and resistant hypertension: the RHOOSAS randomized … M Joyeux-Faure, JP Baguet, G Barone-Rochette, P Faure, P Sosner, ... Frontiers in Neurology 9, 318, 2018 | 54 | 2018 |
| Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: data from randomized trials I Jullian‐Desayes, R Tamisier, JP Zarski, J Aron‐Wisnewsky, ... Respirology 21 (2), 378-385, 2016 | 54 | 2016 |
| Severe central sleep apnea associated with chronic baclofen therapy: a case series PY Olivier, M Joyeux-Faure, T Gentina, SH Launois, MP d’Ortho, JL Pépin, ... Chest 149 (5), e127-e131, 2016 | 52 | 2016 |
| Impact of concomitant medications on obstructive sleep apnoea I Jullian‐Desayes, B Revol, E Chareyre, P Camus, C Villier, JC Borel, ... British journal of clinical pharmacology 83 (4), 688-708, 2017 | 50 | 2017 |
| Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome D Adler, S Bailly, M Benmerad, M Joyeux-Faure, I Jullian-Desayes, ... PloS one 15 (7), e0235331, 2020 | 49 | 2020 |
